▲ Peaking
Business
Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics
Vertex Pharmaceuticals is acquiring commercial endocrinology biotech Crinetics Pharmaceuticals in a $10 billion deal.
1 trends tracked about this subject — the full history, oldest to newest below.
Vertex Pharmaceuticals is acquiring commercial endocrinology biotech Crinetics Pharmaceuticals in a $10 billion deal.